Aptar Beauty Expands Packaging Innovation with NeoDropper
Crystal Lake, Illinois, USA | July 20, 2026 Aptar Beauty has announced the commercial launch of NeoDropper Autoload, its...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Crystal Lake, Illinois, USA | July 20, 2026 Aptar Beauty has announced the commercial launch of NeoDropper Autoload, its...
Zug, Switzerland | July 20, 2026 Galderma announced the expansion of its Alastin® regenerative skincare brand across the Japan...
SCOTTSDALE, Ariz., June 1, 2026 PCA SKIN®, a globally recognized leader in professional skincare and chemical peel innovation, has...
IRVING, Texas, April 9, 2026 Revision Skincare® has announced the publication of two peer-reviewed clinical studies in the Journal...
SANTA MONICA, Calif., March 30, 2026 Beyond Facials, an advanced skincare innovation studio, has introduced its latest breakthrough treatment,...
